Assessment of pathogenicity of VUS in MYBPC3 using CRISPR interference with high-throughput variant expression &functional characterisation (NHMRC Aus Genomics Grant Program administered through VCCRI (2022)
- Grant type:
- Victor Chang Cardiac Research Institute Limited
- Researchers:
-
-
National Heart Foundation of Austra
Institute for Molecular Bioscience
-
- Funded by:
- Victor Chang Cardiac Research Institute Limited
